| 000 | 01773 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518015046.0 | ||
| 264 | 0 | _c20191227 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2018.12.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayer, Felix P | |
| 245 | 0 | 0 |
_aStereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c04 2019 |
||
| 300 |
_a199-209 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic Uptake Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethadone _xanalogs & derivatives |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Catecholamine _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aStereoisomerism |
| 700 | 1 | _aCintulova, Daniela | |
| 700 | 1 | _aPittrich, Dorothea A | |
| 700 | 1 | _aWimmer, Laurin | |
| 700 | 1 | _aLuethi, Dino | |
| 700 | 1 | _aHoly, Marion | |
| 700 | 1 | _aJaentsch, Kathrin | |
| 700 | 1 | _aTischberger, Sonja | |
| 700 | 1 | _aGmeiner, Guenter | |
| 700 | 1 | _aHoener, Marius C | |
| 700 | 1 | _aLiechti, Matthias E | |
| 700 | 1 | _aMihovilovic, Marko D | |
| 700 | 1 | _aSitte, Harald H | |
| 773 | 0 |
_tNeuropharmacology _gvol. 148 _gp. 199-209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2018.12.032 _zAvailable from publisher's website |
| 999 |
_c29222424 _d29222424 |
||